Dentists in Kelseyville, CA Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Ruby C Carlson Larson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9750 State Hwy 281, Ste J, Kelseyville, CA 95451 Phone: 707-277-9100 |
 Dr. Levi Samuel Palmer, D.D.S. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 7275 Adobe Creek Dr, Kelseyville, CA 95451 Phone: 707-263-0629 Fax: 707-263-0629 |
Dr. James Prasert Iamsurey, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4150 Main St, Kelseyville, CA 95451 Phone: 707-279-4251 |
Dr. Prasong Iamsurey, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 4150 Main St, Kelseyville, CA 95451 Phone: 707-279-4251 Fax: 707-279-8335 |
News Archive
Defect in the gene that makes YAP might contribute to cancer
Johns Hopkins scientists have identified a protein in fruit flies whose counterpart product in humans may help cause cancer.
Researchers use gene therapy to prevent learning, memory loss in Alzheimer's mouse model
Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, have used gene therapy to prevent learning and memory loss in a mouse model of Alzheimer's disease (AD), a key step toward eventually testing the approach in humans with the neurodegenerative disease.
Researchers use cutting edge genomic methods to explain protective effects of malaria vaccine candidate
An international team led by researchers from the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health, and Fred Hutchinson Cancer Research Center have used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S).
Blockade Medical's Barricade Coil System receives CE Mark
Blockade Medical announced today that it has received CE Mark (Conformité Européenne) for its Barricade Coil System. The Barricade Coil System is designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Researchers identify potential therapeutic targets for treatment of neuroblastoma
A team of researchers, led by Patrick Mehlen, at Universit- de Lyon, France, has identified the protein NT-3 and the cell-surface molecule to which it binds (TrkC) as potential therapeutic targets for the treatment of neuroblastoma - the most frequent solid tumor in young children- by studying human neuroblastoma cells in vitro and after xenotransplantation into mice and chicks.
› Verified 2 days ago